Average Co-Inventor Count = 10.30
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The United States of America, As Represented by the Secretary, Department of Health and Human Services (16 from 3,539 patents)
2. Institute for Research in Biomedicine (3 from 56 patents)
3. Glaxosmithkline Biologicals Sa (1 from 531 patents)
4. Genvex, Inc. (1 from 1 patent)
16 patents:
1. 12458691 - HIV-1 ENV fusion peptide immunogens and their use
2. 12435113 - Prefusion PIV F immunogens and their use
3. 12275758 - Prefusion RSV F proteins and their use
4. 12053519 - HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
5. 11878998 - Prefusion RSV F proteins and their use
6. 11845778 - Prefusion PIV F immunogens and their use
7. 11780885 - Zika viral antigen constructs
8. 11602559 - HIV-1 Env fusion peptide immunogens and their use
9. 11174292 - Substitutions-modified prefusion RSV F proteins and their use
10. 11078239 - Prefusion PIV F immunogens and their use
11. 10898566 - Zika virus vaccines
12. 10759846 - Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
13. 10301377 - Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
14. 8323961 - HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
15. 7947822 - HIV vaccines based on Env of multiple clades of HIV